Clinical Research at New England Hematology/Oncology Associates for cancers such as breast, prostate, lung, colorectal and gynecological malignancies
Welcome to NEHO

Clinical Research at Newton-Wellesley Hospital and New England Hematology/Oncology Associates, P.C.

Our physicians participate in Clinical Trials, which are research studies designed to offer access to new and potentially more effective treatments. Patients who elect to enter clinical trials are among the first to receive a new treatment. Clinical trials are important because many cancers are unfortunately difficult to treat and careful research may pave the way for enhanced treatment. The latest advances in cancer management are incorporated into many of these trials.

Patients who are interested in trials must meet certain conditions related to type of cancer, previous treatment and physical status. Eligibility is determined by the patient's oncologist along with Newton-Wellesley Hospital's Research Team. Details of each trial are explained in an informed consent statement which must be signed to enter the trial. Patients may withdraw from a research study at any time.

The following are links to sites which provide educational information about general medical, hematology and oncology topics. Although New England Hematology/Oncology, Associates, P.C. periodically reviews these sites, we have no responsibility for their content. These links are listed as an educational service by NEHO.